Publications by authors named "Peter Mutch"

Claim this Profile
A
Absorption, metabolism, and excretion of [C]-sebetralstat (KVD900) following a single oral dose in healthy male participants.
Peter Mutch, Mohammad Bashir, Bonnie Jung, Ping Yi, Matt Iverson

Xenobiotica· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The steady state pharmacokinetics of trientine in Wilson disease patients.
Jan Pfeiffenberger, Carlot Kruse, Peter Mutch, Andrew Harker, Karl Heinz Weiss

Eur J Clin Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.
Eric M Cheung, William J Edenfield, Bassam Mattar, Stephen P Anthony, Peter J Mutch

J Clin Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.
Panayiotis A Procopiou, Victoria J Barrett, Keith Biggadike, Peter R Butchers, Andrew Craven, Peter J Mutch

J Med Chem· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micronucleus induction in the bone marrow of rats by pharmacological mechanisms. II: long-acting beta-2 agonism.
Ingrid Pontén, Peter Mutch, David J Nicholls, Alaa Saad, Cecilia Diaz Pohl

Mutagenesis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings.
Panayiotis A Procopiou, Victoria J Barrett, Nicola J Bevan, Peter R Butchers, Richard Conroy, Peter J Mutch

Bioorg Med Chem· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach.
Panayiotis A Procopiou, Victoria J Barrett, Nicola J Bevan, Keith Biggadike, Philip C Box, Peter J Mutch

J Med Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups.
Panayiotis A Procopiou, Victoria J Barrett, Nicola J Bevan, Keith Biggadike, Peter R Butchers, Peter J Mutch

J Med Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis